Report Categories
View AllRecent Articles
View All
The key risks discussed in CONMED CNMD earnings CONMED notches 65 pct EPS beat topping consensus
ALT Altimmune posts 105 revenue growth but misses Q4 earnings estimates by 102 sparking 675 stock decline
Is Rezolute RZLT stock stabilizing after decline Rezolute posts 154 EPS miss as Q1 loss widens
Zoetis ZTS Stock Is It Testing Levels Q4 2025 EPS Beats Forecasts